Click for best price
Muscle Spasm Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Muscle Spasm Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Muscle Spasm Therapy. This report contains market size and forecasts of Muscle Spasm Therapy in global, including the following market information:
Global Muscle Spasm Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Muscle Spasm Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Muscular Injury Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Muscle Spasm Therapy include Amgen, Inc., Eisai Co., Ltd., Novartis International AG, GlaxoSmithKline plc, AstraZeneca plc, Pfizer, Inc. and F. Hoffmann La Roche Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Muscle Spasm Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Muscle Spasm Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Muscle Spasm Therapy Market Segment Percentages, by Type, 2022 (%)
- Muscular Injury
- Spinal Nerve Compression
- Sprains and Strains of the Muscle Diabetic Ketoacidosis
- Others
Global Muscle Spasm Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Muscle Spasm Therapy Market Segment Percentages, by Application, 2022 (%)
- Construction
- Fire-Fighting
- Sports Apparel
- Automotive
- Aerospace
- Military & Defence
- Industrial
- Others
Global Muscle Spasm Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Muscle Spasm Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Muscle Spasm Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Muscle Spasm Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Amgen, Inc.
- Eisai Co., Ltd.
- Novartis International AG
- GlaxoSmithKline plc
- AstraZeneca plc
- Pfizer, Inc.
- F. Hoffmann La Roche Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Muscle Spasm Therapy, market overview.
Chapter 2: Global Muscle Spasm Therapy market size in revenue.
Chapter 3: Detailed analysis of Muscle Spasm Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Muscle Spasm Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Muscle Spasm Therapy Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Muscle Spasm Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Muscle Spasm Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Muscle Spasm Therapy Overall Market Size
2.1 Global Muscle Spasm Therapy Market Size: 2022 VS 2029
2.2 Global Muscle Spasm Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Muscle Spasm Therapy Players in Global Market
3.2 Top Global Muscle Spasm Therapy Companies Ranked by Revenue
3.3 Global Muscle Spasm Therapy Revenue by Companies
3.4 Top 3 and Top 5 Muscle Spasm Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Muscle Spasm Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Muscle Spasm Therapy Players in Global Market
3.6.1 List of Global Tier 1 Muscle Spasm Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Muscle Spasm Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Muscle Spasm Therapy Market Size Markets, 2022 & 2029
4.1.2 Muscular Injury
4.1.3 Spinal Nerve Compression
4.1.4 Sprains and Strains of the Muscle Diabetic Ketoacidosis
4.1.5 Others
4.2 By Type - Global Muscle Spasm Therapy Revenue & Forecasts
4.2.1 By Type - Global Muscle Spasm Therapy Revenue, 2018-2023
4.2.2 By Type - Global Muscle Spasm Therapy Revenue, 2024-2029
4.2.3 By Type - Global Muscle Spasm Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Muscle Spasm Therapy Market Size, 2022 & 2029
5.1.2 Construction
5.1.3 Fire-Fighting
5.1.4 Sports Apparel
5.1.5 Automotive
5.1.6 Aerospace
5.1.7 Military & Defence
5.1.8 Industrial
5.1.9 Others
5.2 By Application - Global Muscle Spasm Therapy Revenue & Forecasts
5.2.1 By Application - Global Muscle Spasm Therapy Revenue, 2018-2023
5.2.2 By Application - Global Muscle Spasm Therapy Revenue, 2024-2029
5.2.3 By Application - Global Muscle Spasm Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Muscle Spasm Therapy Market Size, 2022 & 2029
6.2 By Region - Global Muscle Spasm Therapy Revenue & Forecasts
6.2.1 By Region - Global Muscle Spasm Therapy Revenue, 2018-2023
6.2.2 By Region - Global Muscle Spasm Therapy Revenue, 2024-2029
6.2.3 By Region - Global Muscle Spasm Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Muscle Spasm Therapy Revenue, 2018-2029
6.3.2 US Muscle Spasm Therapy Market Size, 2018-2029
6.3.3 Canada Muscle Spasm Therapy Market Size, 2018-2029
6.3.4 Mexico Muscle Spasm Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Muscle Spasm Therapy Revenue, 2018-2029
6.4.2 Germany Muscle Spasm Therapy Market Size, 2018-2029
6.4.3 France Muscle Spasm Therapy Market Size, 2018-2029
6.4.4 U.K. Muscle Spasm Therapy Market Size, 2018-2029
6.4.5 Italy Muscle Spasm Therapy Market Size, 2018-2029
6.4.6 Russia Muscle Spasm Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Muscle Spasm Therapy Market Size, 2018-2029
6.4.8 Benelux Muscle Spasm Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Muscle Spasm Therapy Revenue, 2018-2029
6.5.2 China Muscle Spasm Therapy Market Size, 2018-2029
6.5.3 Japan Muscle Spasm Therapy Market Size, 2018-2029
6.5.4 South Korea Muscle Spasm Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Muscle Spasm Therapy Market Size, 2018-2029
6.5.6 India Muscle Spasm Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Muscle Spasm Therapy Revenue, 2018-2029
6.6.2 Brazil Muscle Spasm Therapy Market Size, 2018-2029
6.6.3 Argentina Muscle Spasm Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Muscle Spasm Therapy Revenue, 2018-2029
6.7.2 Turkey Muscle Spasm Therapy Market Size, 2018-2029
6.7.3 Israel Muscle Spasm Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Muscle Spasm Therapy Market Size, 2018-2029
6.7.5 UAE Muscle Spasm Therapy Market Size, 2018-2029
7 Muscle Spasm Therapy Companies Profiles
7.1 Amgen, Inc.
7.1.1 Amgen, Inc. Company Summary
7.1.2 Amgen, Inc. Business Overview
7.1.3 Amgen, Inc. Muscle Spasm Therapy Major Product Offerings
7.1.4 Amgen, Inc. Muscle Spasm Therapy Revenue in Global Market (2018-2023)
7.1.5 Amgen, Inc. Key News & Latest Developments
7.2 Eisai Co., Ltd.
7.2.1 Eisai Co., Ltd. Company Summary
7.2.2 Eisai Co., Ltd. Business Overview
7.2.3 Eisai Co., Ltd. Muscle Spasm Therapy Major Product Offerings
7.2.4 Eisai Co., Ltd. Muscle Spasm Therapy Revenue in Global Market (2018-2023)
7.2.5 Eisai Co., Ltd. Key News & Latest Developments
7.3 Novartis International AG
7.3.1 Novartis International AG Company Summary
7.3.2 Novartis International AG Business Overview
7.3.3 Novartis International AG Muscle Spasm Therapy Major Product Offerings
7.3.4 Novartis International AG Muscle Spasm Therapy Revenue in Global Market (2018-2023)
7.3.5 Novartis International AG Key News & Latest Developments
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Company Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Muscle Spasm Therapy Major Product Offerings
7.4.4 GlaxoSmithKline plc Muscle Spasm Therapy Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline plc Key News & Latest Developments
7.5 AstraZeneca plc
7.5.1 AstraZeneca plc Company Summary
7.5.2 AstraZeneca plc Business Overview
7.5.3 AstraZeneca plc Muscle Spasm Therapy Major Product Offerings
7.5.4 AstraZeneca plc Muscle Spasm Therapy Revenue in Global Market (2018-2023)
7.5.5 AstraZeneca plc Key News & Latest Developments
7.6 Pfizer, Inc.
7.6.1 Pfizer, Inc. Company Summary
7.6.2 Pfizer, Inc. Business Overview
7.6.3 Pfizer, Inc. Muscle Spasm Therapy Major Product Offerings
7.6.4 Pfizer, Inc. Muscle Spasm Therapy Revenue in Global Market (2018-2023)
7.6.5 Pfizer, Inc. Key News & Latest Developments
7.7 F. Hoffmann La Roche Ltd.
7.7.1 F. Hoffmann La Roche Ltd. Company Summary
7.7.2 F. Hoffmann La Roche Ltd. Business Overview
7.7.3 F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Major Product Offerings
7.7.4 F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Revenue in Global Market (2018-2023)
7.7.5 F. Hoffmann La Roche Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Muscle Spasm Therapy Market Opportunities & Trends in Global Market
Table 2. Muscle Spasm Therapy Market Drivers in Global Market
Table 3. Muscle Spasm Therapy Market Restraints in Global Market
Table 4. Key Players of Muscle Spasm Therapy in Global Market
Table 5. Top Muscle Spasm Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Muscle Spasm Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Muscle Spasm Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Muscle Spasm Therapy Product Type
Table 9. List of Global Tier 1 Muscle Spasm Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Muscle Spasm Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Muscle Spasm Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Muscle Spasm Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Muscle Spasm Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Muscle Spasm Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Muscle Spasm Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Muscle Spasm Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Muscle Spasm Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Muscle Spasm Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Muscle Spasm Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Muscle Spasm Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Muscle Spasm Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Muscle Spasm Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Muscle Spasm Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Muscle Spasm Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Amgen, Inc. Company Summary
Table 31. Amgen, Inc. Muscle Spasm Therapy Product Offerings
Table 32. Amgen, Inc. Muscle Spasm Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen, Inc. Key News & Latest Developments
Table 34. Eisai Co., Ltd. Company Summary
Table 35. Eisai Co., Ltd. Muscle Spasm Therapy Product Offerings
Table 36. Eisai Co., Ltd. Muscle Spasm Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Eisai Co., Ltd. Key News & Latest Developments
Table 38. Novartis International AG Company Summary
Table 39. Novartis International AG Muscle Spasm Therapy Product Offerings
Table 40. Novartis International AG Muscle Spasm Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis International AG Key News & Latest Developments
Table 42. GlaxoSmithKline plc Company Summary
Table 43. GlaxoSmithKline plc Muscle Spasm Therapy Product Offerings
Table 44. GlaxoSmithKline plc Muscle Spasm Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline plc Key News & Latest Developments
Table 46. AstraZeneca plc Company Summary
Table 47. AstraZeneca plc Muscle Spasm Therapy Product Offerings
Table 48. AstraZeneca plc Muscle Spasm Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. AstraZeneca plc Key News & Latest Developments
Table 50. Pfizer, Inc. Company Summary
Table 51. Pfizer, Inc. Muscle Spasm Therapy Product Offerings
Table 52. Pfizer, Inc. Muscle Spasm Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer, Inc. Key News & Latest Developments
Table 54. F. Hoffmann La Roche Ltd. Company Summary
Table 55. F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Product Offerings
Table 56. F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. F. Hoffmann La Roche Ltd. Key News & Latest Developments
List of Figures
Figure 1. Muscle Spasm Therapy Segment by Type in 2022
Figure 2. Muscle Spasm Therapy Segment by Application in 2022
Figure 3. Global Muscle Spasm Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Muscle Spasm Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Muscle Spasm Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Muscle Spasm Therapy Revenue in 2022
Figure 8. By Type - Global Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Muscle Spasm Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Muscle Spasm Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 16. US Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 28. China Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Muscle Spasm Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Muscle Spasm Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen, Inc. Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eisai Co., Ltd. Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis International AG Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline plc Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AstraZeneca plc Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer, Inc. Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
